Treatment of canine cutaneous epitheliotropic T-cell lymphoma with oclacitinib: a case report.

Autor: Aslan J; Dermatology for Animals, 263 Appleby Road, Stafford Heights, QLD, 4053, Australia., Shipstone MA; Dermatology for Animals, 263 Appleby Road, Stafford Heights, QLD, 4053, Australia., Sullivan LM; QML Pathology, 11 Riverview Place, Murrarie, QLD, 4172, Australia.
Jazyk: angličtina
Zdroj: Veterinary dermatology [Vet Dermatol] 2021 Aug; Vol. 32 (4), pp. 398-e113. Date of Electronic Publication: 2021 May 25.
DOI: 10.1111/vde.12976
Abstrakt: Canine cutaneous epitheliotropic T-cell lymphoma (CETL) is associated with a poor prognosis and without consistently beneficial treatment options. This case report describes a 9-year-old Staffordshire bull terrier with CETL treated with oclacitinib (0.7 mg/kg twice daily), resulting in partial remission that was maintained for three months. Further studies are warranted.
(© 2021 the European Society of Veterinary Dermatology and the American College of Veterinary Dermatology.)
Databáze: MEDLINE
Externí odkaz: